Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz.
about
Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylationPopulation pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenz.Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.Characterization of biliary conjugates of 4,4'-methylenedianiline in male versus female rats.
P2860
Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@en
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@nl
type
label
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@en
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@nl
prefLabel
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@en
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@nl
P2093
P1476
Liquid chromatography/mass spe ...... criptase inhibitor, efavirenz.
@en
P2093
P304
P577
1999-09-01T00:00:00Z